The histone deacetylase 4/SP1/microrna‐200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma
暂无分享,去创建一个
Fang Wang | Shuhan Sun | Fu Yang | Weiping Zhou | Xi-song Huo | Fang Wang | Shuhan Sun | Fu Yang | Ji-hang Yuan | Bi‐feng Chen | Zhi Lu | Xi-song Huo | Weiping Zhou | Bi-Feng Chen | Z. Lu | Ji-hang Yuan | Weiping Zhou
[1] Shuhan Sun,et al. Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.
[2] Lewis R. Roberts,et al. Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.
[3] 司履生. Cancer epigenetics , 2006 .
[4] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[5] A. Roccaro,et al. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. , 2010, Blood.
[6] Andrew J. Wilson,et al. HDAC4 promotes growth of colon cancer cells via repression of p21. , 2008, Molecular biology of the cell.
[7] G. Goodall,et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. , 2011, The Journal of clinical investigation.
[8] V. Castronovo,et al. HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism , 2009, Oncogene.
[9] V. Richon,et al. Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors. , 2007, Bioorganic & medicinal chemistry letters.
[10] H. Fang,et al. The structure and function of histone deacetylases: the target for anti-cancer therapy. , 2008, Current medicinal chemistry.
[11] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[12] Asad U. Khan,et al. Role of histone acetylation in cell physiology and diseases: An update. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[13] Shuhan Sun,et al. miR‐17‐5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen‐activated protein kinase‐heat shock protein 27 pathway , 2010, Hepatology.
[14] C. Croce,et al. MicroRNA involvement in hepatocellular carcinoma , 2008, Journal of cellular and molecular medicine.
[15] P. Laird. Cancer epigenetics. , 2005, Human molecular genetics.
[16] S. Sharma,et al. Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells. , 2009, International journal of oncology.
[17] F. Huang,et al. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. , 2008, Experimental oncology.
[18] Tae Jin Lee,et al. p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 , 2011, The Journal of experimental medicine.
[19] E. Olson,et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.
[20] C. Benz,et al. Rapid alteration of microRNA levels by histone deacetylase inhibition. , 2006, Cancer research.
[21] P. Atadja. HDAC inhibitors and cancer therapy. , 2011, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[22] M. Grunstein,et al. Functions of site-specific histone acetylation and deacetylation. , 2007, Annual review of biochemistry.
[23] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[24] F. Dequiedt,et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.
[25] Qun Zhou,et al. miR-200a Regulates SIRT1 Expression and Epithelial to Mesenchymal Transition (EMT)-like Transformation in Mammary Epithelial Cells* , 2011, The Journal of Biological Chemistry.
[26] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[27] J. Llovet,et al. Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. , 2010, Seminars in liver disease.
[28] Yue Wang,et al. Down‐regulated microRNA‐152 induces aberrant DNA methylation in hepatitis B virus–related hepatocellular carcinoma by targeting DNA methyltransferase 1 , 2010, Hepatology.
[29] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[30] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[31] R. Büttner,et al. Global histone acetylation levels: Prognostic relevance in patients with renal cell carcinoma , 2010, Cancer science.
[32] M. F. Shannon,et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. , 2008, Cancer research.
[33] A. van Oudenaarden,et al. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. , 2007, Molecular cell.
[34] O. Witt,et al. HDAC family: What are the cancer relevant targets? , 2009, Cancer letters.
[35] T. Hibi,et al. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells , 2009, Oncogene.
[36] Xuegong Zhang,et al. An overview of hepatocellular carcinoma study by omics-based methods. , 2009, Acta biochimica et biophysica Sinica.
[37] R. Place,et al. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer , 2009, Oncogene.
[38] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[39] Jian-Fu Chen,et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.
[40] T. Liang,et al. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma , 2007, Journal of Cancer Research and Clinical Oncology.
[41] C. Zhang,et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells , 2007, The Journal of pathology.
[42] Hao Jiang,et al. HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1 , 2010, Cellular and Molecular Immunology.